Lyell Immunopharma Statistics
Total Valuation
LYEL has a market cap or net worth of $279.31 million. The enterprise value is $62.98 million.
Important Dates
The last earnings date was Wednesday, May 6, 2026, after market close.
| Earnings Date | May 6, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
LYEL has 23.33 million shares outstanding. The number of shares has increased by 38.93% in one year.
| Current Share Class | 23.33M |
| Shares Outstanding | 23.33M |
| Shares Change (YoY) | +38.93% |
| Shares Change (QoQ) | +6.63% |
| Owned by Insiders (%) | 8.12% |
| Owned by Institutions (%) | 33.30% |
| Float | 10.39M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 8,874.48 |
| Forward PS | 13,894.39 |
| PB Ratio | 1.11 |
| P/TBV Ratio | 1.01 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 2,031.71 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 7.23, with a Debt / Equity ratio of 0.18.
| Current Ratio | 7.23 |
| Quick Ratio | 6.88 |
| Debt / Equity | 0.18 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -80.76% and return on invested capital (ROIC) is -32.55%.
| Return on Equity (ROE) | -80.76% |
| Return on Assets (ROA) | -29.87% |
| Return on Invested Capital (ROIC) | -32.55% |
| Return on Capital Employed (ROCE) | -59.45% |
| Weighted Average Cost of Capital (WACC) | 3.18% |
| Revenue Per Employee | $193 |
| Profits Per Employee | -$1.53M |
| Employee Count | 161 |
| Asset Turnover | 0.00 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -11.14% in the last 52 weeks. The beta is -0.09, so LYEL's price volatility has been lower than the market average.
| Beta (5Y) | -0.09 |
| 52-Week Price Change | -11.14% |
| 50-Day Moving Average | 19.92 |
| 200-Day Moving Average | 20.68 |
| Relative Strength Index (RSI) | 23.85 |
| Average Volume (20 Days) | 99,808 |
Short Selling Information
The latest short interest is 1.34 million, so 5.74% of the outstanding shares have been sold short.
| Short Interest | 1.34M |
| Short Previous Month | 1.34M |
| Short % of Shares Out | 5.74% |
| Short % of Float | 12.90% |
| Short Ratio (days to cover) | 20.19 |
Income Statement
In the last 12 months, LYEL had revenue of $31,000 and -$246.41 million in losses. Loss per share was -$13.06.
| Revenue | 31,000 |
| Gross Profit | 31,000 |
| Operating Income | -186.47M |
| Pretax Income | -246.41M |
| Net Income | -246.41M |
| EBITDA | -176.04M |
| EBIT | -186.47M |
| Loss Per Share | -$13.06 |
Full Income StatementBalance Sheet
The company has $254.02 million in cash and $48.85 million in debt, with a net cash position of $212.13 million or $9.09 per share.
| Cash & Cash Equivalents | 254.02M |
| Total Debt | 48.85M |
| Net Cash | 212.13M |
| Net Cash Per Share | $9.09 |
| Equity (Book Value) | 273.67M |
| Book Value Per Share | 11.73 |
| Working Capital | 230.36M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$133.80 million and capital expenditures -$623,000, giving a free cash flow of -$134.42 million.
| Operating Cash Flow | -133.80M |
| Capital Expenditures | -623,000 |
| Depreciation & Amortization | 10.43M |
| Net Borrowing | n/a |
| Free Cash Flow | -134.42M |
| FCF Per Share | -$5.76 |
Full Cash Flow StatementMargins
| Gross Margin | 100.00% |
| Operating Margin | -601,516.13% |
| Pretax Margin | -794,858.06% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
LYEL does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -38.93% |
| Shareholder Yield | -38.93% |
| Earnings Yield | -89.57% |
| FCF Yield | -48.86% |
Analyst Forecast
The average price target for LYEL is $42.20, which is 252.55% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $42.20 |
| Price Target Difference | 252.55% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 5 |
| Revenue Growth Forecast (3Y) | 907.21% |
| EPS Growth Forecast (3Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on June 2, 2025. It was a reverse split with a ratio of 1:20.
| Last Split Date | Jun 2, 2025 |
| Split Type | Reverse |
| Split Ratio | 1:20 |
Scores
LYEL has an Altman Z-Score of -5 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -5 |
| Piotroski F-Score | 1 |
